NFG
GSK icon

Next Financial Group’s GSK GSK Stock Holding History

Next Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1.46M Sell
26,478
-2,948
-10% -$153K 0.1% 236
2021
Q3 		$1.41M Buy
29,426
+693
+2% +$34.8K 0.11% 208
2021
Q2 		$1.43M Buy
28,733
+22,482
+360% +$1.08M 0.11% 201
2021
Q1 		$279K Buy
6,251
+2,963
+90% +$134K 0.02% 657
2020
Q4 		$152K Buy
3,288
+90
+3% +$4.13K 0.01% 817
2020
Q3 		$151K Buy
+3,198
New +$160K 0.02% 714
2020
Q2 		– Sell
-3,334
Closed -$158K – 1115
2020
Q1 		$158K Sell
3,334
-1,601
-32% -$85.4K 0.02% 618
2019
Q4 		$291K Sell
4,935
-1,350
-21% -$75.1K 0.03% 543
2019
Q3 		$336K Buy
6,285
+1,389
+28% +$71.5K 0.04% 461
2019
Q2 		$245K Buy
4,896
+1,044
+27% +$52.4K 0.03% 586
2019
Q1 		$202K Sell
3,852
-1,215
-24% -$60.7K 0.05% 359
2018
Q4 		$242K Sell
5,067
-1,330
-21% -$65.5K 0.05% 348
2018
Q3 		$321K Sell
6,397
-747
-10% -$38K 0.15% 138
2018
Q2 		$360K Sell
7,144
-1,379
-16% -$69.5K 0.14% 176
2018
Q1 		$416K Buy
+8,523
New +$397K 0.09% 245
2017
Q4 		– Sell
-7,822
Closed -$401K – 716
2017
Q3 		$401K Sell
7,822
-2,895
-27% -$147K 0.11% 196
2017
Q2 		$578K Buy
10,717
+95
+0.9% +$5.06K 0.14% 159
2017
Q1 		$543K Sell
10,622
-6,910
-39% -$351K 0.15% 151
2016
Q4 		$844K Buy
17,532
+1,838
+12% +$90.8K 0.15% 157
2016
Q3 		$846K Buy
15,694
+4,968
+46% +$272K 0.15% 150
2016
Q2 		$581K Sell
10,726
-177
-2% -$9.32K 0.18% 126
2016
Q1 		$552K Sell
10,903
-871
-7% -$43.4K 0.19% 119
2015
Q4 		$593K Sell
11,774
-1,655
-12% -$84.4K 0.22% 106
2015
Q3 		$645K Sell
13,429
-2,998
-18% -$156K 0.23% 101
2015
Q2 		$855K Sell
16,427
-4,407
-21% -$248K 0.29% 87
2015
Q1 		$1.2M Buy
20,834
+918
+5% +$52.6K 0.39% 70
2014
Q4 		$1.06M Sell
19,916
-7,973
-29% -$446K 0.35% 69
2014
Q3 		$1.6M Buy
27,889
+18,688
+203% +$1.15M 0.32% 65
2014
Q2 		$536K Buy
+9,201
New +$623K 0.28% 77

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Next Financial Group's GSK Position: Q4 2021 in Review

Next Financial Group reduced its GSK (GSK) stake by 10% in Q4 2021, selling an estimated $153K and leaving 26,478 shares worth $1.46M. The position accounts for 0.1% of the portfolio, ranked #236.

Next Financial Group first reported a position in GSK in Q2 2014 and has held it in 29 quarters since. The position peaked at $1.6M in Q3 2014. 919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

  • Next Financial Group held 26,478 shares of GSK worth $1.46M as of Q4 2021.
  • Next Financial Group sold 2,948 GSK shares in Q4 2021, an estimated $153K.
  • GSK made up 0.1% of Next Financial Group's portfolio in Q4 2021, its #236 holding.
  • Next Financial Group first reported a position in GSK in Q2 2014 and has held it in 29 quarters since.
  • Next Financial Group's GSK position peaked at $1.6M in Q3 2014.
  • 919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.